CervoMed (CRVO) Institutional Ownership → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free CRVO Stock Alerts $19.19 -0.07 (-0.36%) (As of 06/7/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for CervoMed (NASDAQ:CRVO)CurrentInstitutional OwnershipPercentage25.15%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$29.52MNumber ofInstitutional Sellers(last 12 months)0 Get CRVO Insider Trade Alerts Want to know when executives and insiders are buying or selling CervoMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CRVO Institutional Buying and Selling by Quarter Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. CervoMed Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 RA Capital Management L.P.861,573$20.08M0.3%N/A13.964% 5/17/2024 Ikarian Capital LLC237,345$5.53M0.6%N/A3.847% 5/10/2024 Crown Advisors Management Inc.100,000$2.33M1.4%N/A1.621% 2/1/2024 CWM LLC38,253$292K0.0%N/A0.675% 11/15/2023 Rock Springs Capital Management LP80,033$370K0.0%N/A5.885% 11/15/2023 Adage Capital Partners GP L.L.C.199,347$921K0.0%N/A14.658% (Data available from 1/1/2016 forward) CRVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CRVO shares? During the previous two years, the following institutional investors and hedge funds held shares of CervoMed shares: RA Capital Management L.P. ($20.08M), Ikarian Capital LLC ($5.53M), Crown Advisors Management Inc. ($2.33M), Adage Capital Partners GP L.L.C. ($921K), and Rock Springs Capital Management LP ($370K), CWM LLC ($292K).Learn more on CRVO's institutional investors. What percentage of CervoMed stock is owned by institutional investors? 25.15% of CervoMed stock is owned by institutional investors. Learn more on CRVO's institutional investor holdings. Which institutional investors have been buying CervoMed stock? The following institutional investors have purchased CervoMed stock in the last 24 months: RA Capital Management L.P. ($861.57K), Ikarian Capital LLC ($237.35K), Adage Capital Partners GP L.L.C. ($199.35K), Crown Advisors Management Inc. ($100K), Rock Springs Capital Management LP ($80.03K), and CWM LLC ($38.25K). How much institutional buying is happening at CervoMed? Institutional investors have bought a total of 1,516,551 shares in the last 24 months. This purchase volume represents approximately $29.52M in transactions. Related Companies: ACIU Major Shareholders CRBP Major Shareholders ANNX Major Shareholders ERAS Major Shareholders VERV Major Shareholders TBPH Major Shareholders LXRX Major Shareholders ESPR Major Shareholders SLRN Major Shareholders TERN Major Shareholders This page (NASDAQ:CRVO) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CervoMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CervoMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.